Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Tirzepatide for Sale > Meili peptides Tirzepatide 10 mg 15mg 20mg 30mg for body builders
Meili peptides Tirzepatide 10 mg 15mg 20mg 30mg for body builders buy - large image1
Meili peptides Tirzepatide 10 mg 15mg 20mg 30mg for body builders buy - image1
Meili peptides Tirzepatide 10 mg 15mg 20mg 30mg for body builders buy - image2
Meili peptides Tirzepatide 10 mg 15mg 20mg 30mg for body builders buy - image3
Meili peptides Tirzepatide 10 mg 15mg 20mg 30mg for body builders buy - image4
Meili peptides Tirzepatide 10 mg 15mg 20mg 30mg for body builders buy - image5
Meili peptides Tirzepatide 10 mg 15mg 20mg 30mg for body builders buy - image6

Meili peptides Tirzepatide 10 mg 15mg 20mg 30mg for body builders

TDS 2103 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Hongkong

Brand:

Meili Peptides

Packaging:

10vilas/kit

Sample Available:

Yes

Price valid (until):

2026-10-17

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Reta, Tirz, Sema, Cosmetic Products

  • Product Details

  • Seller Information

  • History Price

  • Inquiry History

  • Description


      Product Detail  


    Name Tirzepatide 
    Origin China
    Peptide Form Lyophilized Powder
    Peptide Package 10 Vials per kit
    Peptide Purity No less than 99%
    Peptide MOQ: 1 kit (10 vials)
    Specification 10mg 15mg 20mg 30mg 40mg 50mg 60 mg 100mg 120mg
    Shop China peptide Retatrutide 10mg 20mg 30mg lyophilized powder-Detailed Image 1

    Shop China peptide Retatrutide 10mg 20mg 30mg lyophilized powder-Detailed Image 2

    Tirzepatide


      Key Features & Potential Benefits


    Retatrutide

    ✅1. Triple-Action Mechanism Simultaneously activates GLP-1, GIP, and glucagon receptors for synergistic metabolic effects.

    ✅2. Enhanced Weight Management Promotes sustained weight loss by reducing appetite, increasing energy expenditure, and improving fat oxidation.

    ✅3. Improved Glycemic Control Helps regulate blood sugar levels, making it a promising candidate for metabolic syndrome and type 2 diabetes management.

    ✅4. Potential Liver Health Support Early studies suggest benefits in reducing liver fat and improving markers of metabolic dysfunction-associated steatotic liver disease (MASLD).


    Tirzepatide 

    • ✅ Superior weight loss (~20-21% at 72 weeks)

    • ✅ Powerful glycemic control (HbA1c reduction up to 2.5%)

    • ✅ Cardiovascular and kidney protection

    • ✅ Multiple metabolic benefits (liver, lipids, blood pressure)


    Semaglutide

    ✅ 1. Glycemic Control (Type 2 Diabetes)

    Semaglutide is highly effective at lowering HbA1c and fasting plasma glucose. Clinical trials such as SUSTAIN and PIONEER have consistently demonstrated significant reductions in blood sugar levels. As a result, semaglutide has become a cornerstone therapy for the management of Type 2 Diabetes Mellitus (T2DM), particularly for patients who require enhanced glycemic control beyond metformin alone.

    ✅  2. Weight Management (Obesity)

    By reducing appetite and delaying gastric emptying, semaglutide promotes substantial and sustained weight loss. The landmark STEP clinical trials showed that participants achieved up to 15–20% body weight reduction over 68 weeks. It is FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related comorbidity, such as hypertension, dyslipidemia, or type 2 diabetes.

    ✅ 3. Cardiovascular Protection

    Semaglutide has demonstrated significant cardiovascular benefits beyond glucose control. The SUSTAIN-6 and SELECT trials showed a clear reduction in Major Adverse Cardiovascular Events (MACE), including cardiovascular death, non-fatal myocardial infarction (heart attack), and non-fatal stroke. Importantly, these benefits have been observed in patients both with and without type 2 diabetes, highlighting its broader cardioprotective potential.

    ✅ 4. Additional Multi-Organ Benefits

    Emerging research indicates that semaglutide offers protective effects beyond weight and blood sugar management:

    • Renoprotective: The FLOW trial demonstrated that semaglutide slows the progression of chronic kidney disease (CKD) and reduces albuminuria in diabetic patients, making it a valuable option for kidney health.

    • Liver Health: Semaglutide improves liver enzymes, reduces hepatic steatosis (fatty liver), and shows strong potential in managing Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH).

    • Anti-inflammatory: It helps reduce systemic inflammation and oxidative stress in metabolic tissues, which may contribute to overall metabolic health.

    • PCOS: Semaglutide also aids in managing obesity and resistance associated with Polycystic Ovary Syndrome (PCOS), offering benefits for reproductive and metabolic health in affected women.



      Product Package  


    Shop China peptide Retatrutide 10mg 20mg 30mg lyophilized powder-Detailed Image 3

      Customer Feedbacks 





    Shop China peptide Retatrutide 10mg 20mg 30mg lyophilized powder-Detailed Image 5 Shop China peptide Retatrutide 10mg 20mg 30mg lyophilized powder-Detailed Image 6 Shop China peptide Retatrutide 10mg 20mg 30mg lyophilized powder-Detailed Image 7 Shop China peptide Retatrutide 10mg 20mg 30mg lyophilized powder-Detailed Image 8


      Shipment Records 


    Shop China peptide Retatrutide 10mg 20mg 30mg lyophilized powder-Detailed Image 9 Shop China peptide Retatrutide 10mg 20mg 30mg lyophilized powder-Detailed Image 10 Shop China peptide Retatrutide 10mg 20mg 30mg lyophilized powder-Detailed Image 11 Shop China peptide Retatrutide 10mg 20mg 30mg lyophilized powder-Detailed Image 12

    FAQ

    Q: How to order this product?

    A: You can contact us via whatsapp or email for more information.

    Q: How long can I receive my ordered goods?

    A: Door to door service ,  about 8-15 days.

    Q: What's your MOQ?

    A: For the regular products, our MOQ is 1box, 1 box has 10 vials.

    Q: Is there a discount?

    A: Yes, bulk order with big discount.


      Company Profile


    Shop China peptide Retatrutide 10mg 20mg 30mg lyophilized powder-Detailed Image 13

    Our company is a professional company, specializing in the production of beauty products, healthy products.

    MeiL is dedicated to providing the highest standards of product quality and safety compliance.

    We closely monitor our customer's compliance programs and adhere to international laws and regulations, including those of the U.S. and Europe.

    We recognize the challenges posed by geographic distance, language barriers, cultural differences, and the need for on-site quality control and inspection.

    Hence, we strive to mitigate these challenges, ensuring a seamless and reliable sourcing experience from us.

    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Certificates

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Polypeptide

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Reta, Tirz, Sema, Cosmetic Products

    Location:

    Guangzhou Yuexiu Strict NongLin Road NO. 81

    Total Employees:

    11-50

    Year of Establishment:

    2026

    MeiLi Biotechnology Co. Ltd is a professional company specializing in the production of beauty products, healthy products. MeiLi is dedicated to providing the highest standards of product quality and safety compliance to customers.

    We closely monitor our customer's compliance programs and adhere to international laws and regulations, including those of the U.S. and Europe. We recognize the challenges posed by geographic distance, language barriers, cultural differences, and the need for on-site quality control and inspection. Hence, we strive to mitigate these challenges, ensuring a seamless and reliable sourcing experience from us.

    Choosing us, you will have a reliable partner, best quality products, fast and safe delivery, and worry-free after- sales experience. Sincerely hope that we could have long term cooperative relations with our customers and achieve a win-win situation.

  • Weekly Price

    The chart shows the price trend of the product in the past 12 months.

  • Inquiry History
    2103 Inquiries
    Country Product Purchase Quantity Date Posted
    Brazil

    Tirzepatide

    100 G Oct 28, 2026
    Belgium

    Tirzepatide

    10 MG Oct 28, 2026
    United States

    tirzepatide

    100 MG Oct 28, 2026
    United States

    Tirzepatide

    60 MG Oct 28, 2026
    United States

    Tirzepatide

    10 PCS Oct 28, 2026
    United States

    tirzepatide

    30 MG Oct 27, 2026
    United States

    Tirzepatide

    40 MG Oct 27, 2026
    Philippines

    Tirzepatide

    2 MT Oct 27, 2026
    Philippines

    Tirzepatide

    30 MG Oct 26, 2026
    Slovakia

    Tirzepatide

    1 G Oct 26, 2026
    France

    Tirzepatide

    1 KG Oct 25, 2026
    United States

    Tirzepatide

    2.5 MG Oct 25, 2026
    United Kingdom

    Tirzepatide

    5 MT Oct 25, 2026
    United Kingdom

    Tirzepatide

    6 MT Oct 24, 2026
    Peru

    tirzepatide

    10 MG Oct 21, 2026
    Puerto Rico

    tirzepatide

    40 MG Oct 21, 2026
    United States

    Tirzepatide

    10 MT Oct 21, 2026
    South Africa

    Tirzepatide

    1 MT Oct 20, 2026
    United States

    Tirzepatide

    5 KG Oct 20, 2026
    United States

    tirzepatide

    30 MG Oct 20, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.